Skip to content
Medical Health Aged Care

Sick at Home? Australians Turn to Simple, Affordable Online Doctor Access as GP Wait Blow Out

medmate 2 mins read
As winter viruses surge across Australia, thousands of patients are turning to fast, affordable online doctors to avoid long waits and overwhelmed clinics.
Medmate, Australia’s leading digital health service, has recorded a 40% surge in cold and flu consultations over the past month, with influenza, RSV, and COVID-19 driving a sharp uptick in demand.
“We’re seeing a clear shift in how Australians want to access care,” said Dr Ganesh Naidoo, Medmate Founder and practising GP. “When you’re unwell at home, the last thing you want is to wait two weeks for a GP appointment or spend hours in an emergency department.”
Medmate provides real-time telehealth consultations with credentialed Australian doctors with backgrounds in general practice, urgent care, and emergency medicine. Patients speak to a doctor in as little as 15 minutes, with services starting from just $19.90 for eligible consultations.
“Our service is designed to be simple , safe and clinically sound,” said Dr Naidoo. “Our doctors know when a patient can be safely managed at home, and when escalation is required. That keeps people out of hospital and supports a more efficient health system.”
Medmate operates 7 days a week, allowing patients to access prescriptions, medical certificates, referrals and clinical advice from anywhere in Australia — all without leaving home.
As GP wait times stretch beyond 10–14 days in many parts of the country, and emergency departments report rising presentations for minor respiratory illness and fever, services like Medmate are filling a critical gap in the healthcare system.
“This is about smart, accessible care,” said Dr Naidoo. “We’re giving Australians a trusted clinical alternative that’s safe, affordable, and aligned with robust national telehealth standards — and we’re doing it at a time when the system needs it most.”
Data from Medmate’s national heatmap shows the biggest surges in demand are in colder southern states — including Victoria, Tasmania, and New South Wales — where flu season is peaking and traditional clinics are under strain.

Contact details:

For more information, please contact:

Alicia Hall / Project PR / [email protected] / 0401 878 496

Media

More from this category

  • Medical Health Aged Care, Research Development
  • 11/07/2025
  • 16:28
The Florey

Harnessing mRNA to prevent and slow Alzheimer’s disease

mRNA Victoria funds 2Floreyprojects to prevent and treat Alzheimer’s disease Key points mRNA Victoria has funded 2 Alzheimer’s disease research projects that could position Victoria as a leader in the development of mRNA-based therapies. Dr Abdel Belaidi will develop an mRNA-based system that crosses the blood-brain barrier and aims to slow or even halt disease progression. Dr Rebecca Nisbet will develop an mRNA vaccine that aims to prevent Alzheimer’s disease from developing. Florey researchers working at the cutting edge of dementia research have received funding from mRNA Victoria to develop treatments and a vaccine for Alzheimer’s disease. Since mRNA vaccines…

  • Medical Health Aged Care
  • 11/07/2025
  • 07:05
Royal Australian College of GPs

GPs urge Tasmanian families to get vaccinated against whooping cough and call for free shots to reduce barriers

The Royal Australian College of GPs (RACGP) is urging Tasmanian families to get vaccinated against pertussis, or ‘whooping cough’ and called on all parties and candidates running in the state election to commit to making the vaccination free for all patients. From 1 January 2024 to April 2025, 1238 whooping cough cases were notified in Tasmania, including 10 infants aged under six months. Most hospitalisations and deaths occur in this group, who are not old enough to have received all vaccine doses. More than 21,000 infections were recorded nationwide last year, compared to just 2450 in 2023, and the National…

  • Contains:
  • General News, Medical Health Aged Care
  • 11/07/2025
  • 07:00
La Trobe University

La Trobe researchers awarded $4.5 million in ARC Future Fellowships

LaTrobe University researchers have secured almost $4.5 million in Federal Government funding to further studies into areas such as immune cell development, Australian history and agriculture. Four researchers received an Australian Research Council (ARC) Future Fellowship 2025. The prestigious Future Fellowships support high quality research in areas of national and international benefit, including in national research priorities. Dr Lisa Mielke, from the School of Cancer Medicine, the La Trobe Institute of Molecular Science (LIMS) and the Olivia Newton-John Cancer Research Institute (ONJCRI), received $1.13 million to identify new molecules for future drug and vaccine development to improve gut health in…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.